Strategies for Managing Neurotoxic AEs With Lorlatinib

Opinion
Video

Key opinion leaders discuss strategies for managing neurotoxicity with lorlatinib and other ALK inhibitors, including monitoring adverse events and balancing symptom management with treatment efficacy.

Video content above is prompted by the following:

  • Can you discuss your strategies for managing neurotoxicity?
  • How are you monitoring these AEs?
  • How do you balance symptom management with maintaining treatment efficacy?

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with red hair and glasses wearing a black blouse and cross necklace in front of a dark blue background
Photo of a man wearing a suit with a blue tie in front of a dark blue background
4 experts in this video
4 experts in this video
Photo of a man wearing glasses and a suit in front of a blue background
Related Content